FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (X) and their salts and to their application as intermediate compounds in method of obtaining pharmaceutically active compound of formula (I), where X represents =O or =N-OH; Y represents hydrogen or para-chlorophenylsulphanyl; Z represents hydrogen or -CH2COOR1, where R1 is selected from hydrogen and alkyl.
EFFECT: obtaining novel compounds.
9 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
INDOLE AND BENZOMORPHOLINE DERIVATIVES AS MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2517181C2 |
1-(2-ISOPROPOXYETHYL)-2-THIOXO-1,2,3,5-TETRAHYDRO-PYRROLO[3,2-d]PYRIMIDIN-4-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2005 |
|
RU2409578C2 |
IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
METHOD OF SYNTHESISING DERIVATIVES OF AMINO-METHYL TETRALIN | 2009 |
|
RU2512285C2 |
NEW SUBSTITUTED N-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE (IDO) | 2018 |
|
RU2765371C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
DERIVATIVES OF 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-a]INDOLE-ACETIC ACID AND USE THEREOF AS PROSTAGLANDIN D2 RECEPTOR MODULATORS | 2012 |
|
RU2596823C2 |
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
Authors
Dates
2015-05-27—Published
2010-07-05—Filed